Serum cholesterol levels and kidney transplantation outcome: Attenuation of cyclosporine efficacy?

被引：6

作者：

Hirano, T

Akashi, T

Oka, K

Yoshida, M

Matsuno, N

Nagao, T

机构：

[1] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Clin Pharmacol, Hachioji, Tokyo 1920392, Japan

[2] Tokyo Med Univ, Hachioji Med Ctr, Dept Pharmaceut, Hachioji, Tokyo, Japan

[3] Tokyo Med Univ, Hachioji Med Ctr, Dept Internal Med, Renal Unit, Hachioji, Tokyo, Japan

[4] Tokyo Med Univ, Hachioji Med Ctr, Dept Surg 5, Hachioji, Tokyo, Japan

来源：

TRANSPLANTATION | 2001年 / 71卷 / 05期

关键词：

D O I：

10.1097/00007890-200103150-00014

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 [免疫学];

摘要：

引用

页码：659 / 660

页数：2

共 7 条

[1]

DEGROEN PC, 1988, TRANSPL P, V20, P374

[2]

GURECKI J, 1985, TRANSPLANT P, V17, P1997

[3]

INGULLI E, 1992, J AM SOC NEPHROL, V3, P254

[4]

RAINE AEG, 1992, NEPHROL DIAL TRANSPL, V7, P7

[5]

Roodnat JI, 2000, TRANSPLANTATION, V69, P1704

[6]

SANGHVI A, 1987, TRANSPLANT P, V19, P45

[7]

THE ASSOCIATION OF LDL RECEPTOR ACTIVITY, LDL CHOLESTEROL LEVEL, AND CLINICAL COURSE IN HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA [J].

SPRECHER, DL ;

HOEG, JM ;

SCHAEFER, EJ ;

ZECH, LA ;

GREGG, RE ;

LAKATOS, E ;

BREWER, HB .

METABOLISM-CLINICAL AND EXPERIMENTAL, 1985, 34 (03) :294-299

← 1 →